Developing new compounds info safe, effective and marketable therapeutic drugs

GizaVC invests in the vision of Israel's most innovative entrepreneurs.


BioLineRx is a biopharmaceutical development company dedicated to identifying, in-licensing and developing therapeutic candidates for unmet medical needs or that have advantages over currently available therapies. BioLineRx’s development pipeline consists of five clinical stage candidates as well as 11 candidates in various pre-clinical stages for indications including CNS, oncology, cardiovascular and autoimmune diseases. Two of BioLineRx's lead compounds have been out-licensed for continuation of development and commercialization.

bioline C



CEO: Dr. Kinneret Savitsky      COO & CFO: Phil Serlin



Fields of invesment: icon lifeHealthcare

Contact info: Website